GlucoStation non-invasive blood glucose monitor ready for pre-order as GlucoActive develops two other painless measurement devices
GlucoActive, a Polish start-up based in Wrocław, has just completed another investment round for its blood glucose measurement technology. The first device that should reach the market is the GlucoStation, which is aimed for use in the home or in workplaces such as clinics, hospitals, and pharmacies. According to the firm, the GlucoStation is targeted at people with type II diabetes, currently estimated at 90% of all diabetes-related cases.
Apparently, the GlucoStation uses non-invasive laser light waves (optical – spectrophotometrical) that can penetrate the skin allowing blood glucose measurements to be taken by the device itself. All the user has to do is place their forearm on the GlucoStation and wait for a moment for the process to take place. According to GlucoActive’s roadmap, the finished product is ready for medical certification, with a planned release taking place in 2023.
In fact, the GlucoStation is actually already available for pre-order and is reduced for early-bird buyers – down from €999 to €699 (~US$1,052 to US$736). Reservations can be made for free, with delivery expected to begin in January 2023. The GlucoStation doesn’t require any strips or sensors for regular use but requires a one-time calibration, which involves the use of blood test strips. Measurement accuracy for the device has been published at +-15% (at the ISO standard for glucometers).
As the 2.2 kg/4.4 lbs painless and non-invasive glucose monitor may not be suitable for users with a more active lifestyle, GlucoActive is also working on two wearable blood sugar measurement devices: the GlucoFit and the GlucoWear. The former comes in the shape of an armband while the latter looks like a typical smartwatch, with both offering continuous glucose monitoring for users with either type 1 or type II diabetes.
One of the co-founders of the company, Maciej Wysocki, claims that patients could save up to 12,000 Polish złoty (~US$2,693) a year using either the GlucoFit or GlucoWear monitors because of the non-requirement of typical, and sometimes costly, diabetes-management paraphernalia. No planned release date has been posted for either of the wearable alternatives at the moment.